Literature DB >> 26350056

Evaluation of PAX8 Expression and Its Potential Diagnostic and Prognostic Value in Renal and Extra-Renal Ewing Sarcomas/PNETs.

Michael Markow1, Marilyn M Bui1,2,3, Hui-Yi Lin4, Mark Lloyd2, Wade J Sexton5, Jasreman Dhillon6,7.   

Abstract

PAX8 is a transcription factor involved in the regulation of organogenesis of the thyroid gland, kidney, and Müllerian system. It is commonly expressed in epithelial tumors of thyroid and parathyroid glands, kidney, thymus, and female genital tract. PAX8 is increasingly used in the establishment of tissue of origin in carcinomas and has recently been identified in a subset of small blue round cell tumors including Ewing sarcomas/PNETs. However, it is unclear if this association in ES/PNETs is due to renal origin or is PNET specific. In this study we investigated the PAX8 staining pattern of primary renal and extra-renal ES/PNETs to explore its potential diagnostic and prognostic role. A tissue microarray (TMA) of 22 cases of extra-renal Ewing/PNETs and two separate cases of primary renal PNET whole slide sections were immunohistochemically stained with rabbit polyclonal PAX8 antibody. PAX8 was positive in 2 of 2 primary renal PNETs and in 14 (64 %) cases of the extra renal PNETs. The association between PAX8 immunoreactivity and Ewing/PNET was identified in both primary renal and extra-renal Ewing/PNETs for the first time. Further studies are warranted to verify these findings and to shed light in the tumorigenesis of Ewing/PNET. However, PAX8 is not useful in establishing a diagnosis of Ewing/PNET due to its presence in different tumors like carcinomas, lymphomas and sarcomas. PAX8 does not seem to have prognostic value.

Entities:  

Keywords:  PAX8; PNET; Renal PNET

Mesh:

Substances:

Year:  2015        PMID: 26350056     DOI: 10.1007/s12253-015-9986-8

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  16 in total

1.  Expression of PAX8 in normal and neoplastic tissues: a comprehensive immunohistochemical study.

Authors:  David Tacha; Ding Zhou; Liang Cheng
Journal:  Appl Immunohistochem Mol Morphol       Date:  2011-07

2.  PAX8 and PAX5 are differentially expressed in B-cell and T-cell lymphomas.

Authors:  Elizabeth A Morgan; Olga Pozdnyakova; Alessandra F Nascimento; Michelle S Hirsch
Journal:  Histopathology       Date:  2012-11-16       Impact factor: 5.087

3.  PAX8 expression in uterine malignant mesodermal mixed tumor (carcinosarcoma).

Authors:  Brittany J Holmes; Allen M Gown; Russell Vang; Brigitte M Ronnett; Anna Yemelyanova
Journal:  Int J Gynecol Pathol       Date:  2014-07       Impact factor: 2.762

4.  Targeting the EWSR1-FLI1 oncogene-induced protein kinase PKC-β abolishes ewing sarcoma growth.

Authors:  Didier Surdez; Magdalena Benetkiewicz; Virginie Perrin; Zhi-Yan Han; Gaëlle Pierron; Stelly Ballet; François Lamoureux; Françoise Rédini; Anne-Valérie Decouvelaere; Estelle Daudigeos-Dubus; Birgit Geoerger; Gonzague de Pinieux; Olivier Delattre; Franck Tirode
Journal:  Cancer Res       Date:  2012-08-28       Impact factor: 12.701

5.  PAX2(-)/PAX8(-)/inhibin A(+) immunoprofile in hemangioblastoma: A helpful combination in the differential diagnosis with metastatic clear cell renal cell carcinoma to the central nervous system.

Authors:  Erin M Carney; Priya Banerjee; Carla L Ellis; Roula Albadine; Rajni Sharma; Alcides M Chaux; Peter C Burger; George J Netto
Journal:  Am J Surg Pathol       Date:  2011-02       Impact factor: 6.394

6.  A comprehensive analysis of PAX8 expression in human epithelial tumors.

Authors:  Anna R Laury; Ruth Perets; Huiying Piao; Jeffrey F Krane; Justine A Barletta; Christopher French; Lucian R Chirieac; Rosina Lis; Massimo Loda; Jason L Hornick; Ronny Drapkin; Michelle S Hirsch
Journal:  Am J Surg Pathol       Date:  2011-06       Impact factor: 6.394

Review 7.  Value of PAX 8 immunostaining in tumor diagnosis: a review and update.

Authors:  Nelson G Ordóñez
Journal:  Adv Anat Pathol       Date:  2012-05       Impact factor: 3.875

8.  Use of PAX8 and GATA3 in diagnosing sarcomatoid renal cell carcinoma and sarcomatoid urothelial carcinoma.

Authors:  Alex Chang; Fadi Brimo; Elizabeth A Montgomery; Jonathan I Epstein
Journal:  Hum Pathol       Date:  2013-02-28       Impact factor: 3.466

9.  PAX-8 expression in primary and metastatic Merkel cell carcinoma: an immunohistochemical analysis.

Authors:  Ankur R Sangoi; David S Cassarino
Journal:  Am J Dermatopathol       Date:  2013-06       Impact factor: 1.533

10.  PAX8 expression in sporadic hemangioblastoma of the kidney supports a primary renal cell lineage: implications for differential diagnosis.

Authors:  Ming Zhao; Sean R Williamson; Jingjing Yu; Wenping Xia; Changshui Li; Jiangjiang Zheng; Yin Zhu; Ke Sun; Zhaoming Wang; Liang Cheng
Journal:  Hum Pathol       Date:  2013-07-10       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.